Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation

Leukemia and Lymphoma

Volumn 37, Issue 5-6, 2000, Pages 535-542

  Martínez, Carmen ^a   Urbano Ispizua, Alvaro ^b   Rovira, Montserrat ^b   Carreras, Enric ^b   Rozman, Ciril ^b   Montserrat, Emilio ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

Allogeneic transplantation; Immune reconstitution; Peripheral blood

Indexed keywords

ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CANCER IMMUNOLOGY; CANCER MORTALITY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INFECTION COMPLICATION; MALE; META ANALYSIS; PRIORITY JOURNAL; T LYMPHOCYTE; CELL LINEAGE; GRAFT SURVIVAL; HEMATOPOIESIS; HISTOCOMPATIBILITY; IMMUNOCOMPETENCE; IMMUNOLOGY; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REVIEW; STEM CELL MOBILIZATION;

CYTOKINE;

ADOLESCENT; ADULT; CELL LINEAGE; CYTOKINES; FEMALE; GRAFT SURVIVAL; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; IMMUNOCOMPETENCE; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0342657773     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009058505     Document Type: Article

References (43)

1. Farman S.J., Blume K.G., Thomas D.E. (eds) (1994) Bone Marrow Transplantation. Parkman R. Immunological reconstitution following bone marrow transplantation. pp 504-512. Blackwell Scientific Publications, Boston MA, USA.
2. Storek J., Witherspoon R.P., and Storb R. (1995). T cell reconstitution after hone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant, 16, 413-425.
3. Small T., Keever C., and Weiner-Fedus S. (1990). B-cell differentiation following autologous, conventional, or T-cell depleted hone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood, 76, 1647-1656.
4. De Gast G.C., Verdonck L.F., and Middeldorp J.M. (1985). Recovery of T cell subsets alter autologous bone marrow transplantation is mainly due to proliferation of mature T cells in the graft. Blood, 66, 428-431.
5. Mackall C., Granger L., Sheard M., Cepeda R., and Gress R. (1993). T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood, 82, 2585-2594.
6. Henon P.R., Liang H., Beck-Wirth G., Eisenmann J.C., Lepers M., Wunder E., and Kandel G. (1992). Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant, 12, 285-291.
7. Roberts M.M., To L.B., Gillis D., Mundy J., Rawling C., Ng K., and Juttner C.A. (1993). Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant, 12, 469-175.
8. Talmadge J.E., Reed E., Ino K., Kenssinger A., Kuszynski C., Heimann D., Varney M., Jackson J., Vose J.M., and Bierman P.J. (1997). Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant, 19, 161-172.
9. Tjonnfjord G.E., Steen R., Evensen S.A., Thorsby E., and Egeland T. (1994). Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood, 84, 2795-2801.
10. Dreger P., Haferlach T., Eckstein V., Jacobs S., Suttorp M., Loffler H., Muller-Rucholtz W., and Schmitz N. (1994). G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft. Br J Haematol, 87, 609-613.
11. Martínez C., Urbano-Ispizua A., Rozman C., Marín P., Mazzara R., Carreras E., Rovira M., Sierra J., Briones J., Ordinas A., and Montserrat E. (1996). Effects of G-CSF administration and peripheral blood progenitor cells collections in 20 healthy donors. Ann of Hematol, 72, 269-272.
12. + T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donors. Blood, 89, 2586-2595.
13. Pan L., Delmonte J., Jalonen C.K., and Ferrara J.L. (1995). Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T-lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood, 86, 4422-4429.
14. Krenger W., Snyder K.M., and Byon J.H.C. (1995). Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol, 155, 585-593.
15. Atkinson K. (1990). Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant, 5, 209-226.
16. Martínez C., Urbano-Ispizua A., Rozman C., Marín P., Rovira M., Sierra J., Montfort N., Carreras E., Montserrat E. (1999). Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts. Experimental Hematology, 27, 561-568.
17. Pavletic Z.S., Joshi S.S., Pirruccello S.J., Tarantolo S.R., Kollath J., Reed E.C., Bierman P.J., Vose J.M., Wakentin P.I., Gross T.G., Nasrati K., Armitage J.O., Kessinger A., and Bishop M.R. (1998). Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant, 21, 33-41.
18. Keever C., Small T., Flomenberg N., Heller G., Pekle K., Black P., Pecora A., Gillio A., Kernan N., O'Reilly R. (1989). Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood, 73. 1340-1350.
19. Parkman R., Weinberg K. (1997). Immunological reconstitution following bone marrow transplantation, Immunological Reviews, 157, 73-78.
20. Ottinger H.D., Beelen D.W., Scheulen B., Schaefer U.W., and Grosse-Wilde H. (1996). Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood, 88, 2775-2779.
21. Storek J., Witherspoon R.P., Maloney D.G., Chauncey T.R., and Storb R. (1997). Improved reconstitution of CD4 T cells and B cells but worsened reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrow. Blood, 89, 3891-3893.
22. Shenoy S., Mohanakumar T., Todd G., Westhoff W., Dunnigan K., Adkins D.R., Brown R.A., and DiPersio J.F. (1999). Immune reconstitution following peripheral blood stem cell transplants. Bone Marrow Transplant, 23, 335-349.
23. Vacca A., Felli M.P., Farina A.R., Martinotti S., Maroder M., Screpanti I., Meco D., Pentrangeli E., Frati L., Gulino A. (1992). Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperatively between nuclear factor of activated T cells and AP-1 enhanced elements. J Exp Med, 175, 637-646.
24. Fernandez-Ruiz E., Rebollo A., and Nieto M.A. (1989). IL-2 protects T cells hybrids from the cytolytic effect of glucocorticoids. Synergistic effect of IL-2 and dexamethasone in the induction of high-affinity IL-2 receptors. J Immunol, 143, 4146-4151.
25. Lanza L., Scudeletti M., Puppo F., Bosco O., Peirano L., Filaci G., Fecarotta E., Vidali G., and Indiveri F. (1996). Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes. Clin Exp Immunol, 103, 482-490.
26. Mackall C., Granger L., Sheard M., Cepeda R., and Gress R. (1993). T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood, 82, 2585-2594.
27. Mackall C., Fleisher T., Brown M., Andrich M., Chen C., Feuerstein I., Horowitz M., Magrath I., Shad A., Steinberg S., Wexler L., and Gress R. (1995). Age. thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Eng J Med, 332, 143-149.
28. Mackall C. and Gress R. (1997). Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunological Reviews, 157, 61-72.
29. Bacigalupo A., Mordini N., Pitto A., Piaggio G., Podesta M., Benvenuto F., Van Lint M., Valbonesi M., Lercari G., Carlier P., Lamparelli T., Gualandi F., Occhini D., Bregante S., Figari O., Soracco M., Vassalo F., and De Stefano G. (1997). Transplantation of HLA-mismatched CD34+ selected cells in patients with advanced malignancies: severe immunodeficiency and related complications. Br J Haematol, 98, 760-766.
30. Aversa F, Tabilio A., Terenzi A., Velardi A., Falzetti F., Giannoni C., Iacucci R., Zei T., Martelli M., Gambeluinghe C., Rossetti M., Caputo P., Latini P., Arestei C., Raymondi C., Reisner Y., and Martelli M. (1994). Successful engraftment of T-cell depleted "three loci" incompatible transplants in leukemia patients by addition of granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood, 84, 3948-3955.
31. Rosillo M.C., Ortuño F., Moraleda J.M., Lozano M.L., Heras I., De Arriha F., and Vicente V. (1996). Immune recovery after autologous or rhG-CSF primed PBSC transplantation. Eur J Haematol, 56, 301-307.
32. Bensinger W., Weaver C.H., Appelbaum F.R., Rowley S., Demirer T., Sanders J., Storb R., and Buckner C.D. (1995). Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood, 85, 1655-1658.
33. Schmitz N., Dreger P., Suttorp M., Rohwedder E.B., Haferlach T., Löeffler H., Hunter A.E., and Russell N.H. (1995). Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood, 85, 1666-1672.
34. dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host-disease. Blood, 86, 2842-2848.
35. Bensinger W., Buckner M., Shanon-Dorcy K., Rowley S., Appelbaum F, Benyunes M., Cliff R., Martin P., Demirer T., Storb R., Lee M., and Schiller G. (1996). Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. Blood, 88, 4132-4138.
36. Schmitz N., Bacigalupo A., Hasenclever D., Nagler J., Gluckman E., Clark P., Varet B., Greinix H., Frickhofen N., Ringden O., Zander A., Apperley J., Gorin N., Borkett K., Schwab G., Goebel M., Russell N.H., and Gratwohl A. (1998). Allogeneic bone marrow transplantation versus filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukemia: results of a randomized multicentre study. Bone Marrow Transplant, 21, 995-1003.
37. Korbling M., Mirze N., Przepiorka D., Anderlini P., Chan K., and Champlin R. (1997). Clinical outcome of 112 patients following HLA-identical allogeneic peripheral blood stem cell transplantation. Blood, 10 (Suppl. 1), 224a.
38. Storek J., Gooley T., Siadak M., Bensinger W., Maloney D., Chauncey T., Flowers M., Sullivan K., Witherspoon R., Rowley S., Hansen J., Storb R., and Appelbaum F. (1997). Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood, 90, 4705-4709.
39. Solano C., Martínez C., Brunet S., Tomas J.F., Urbano-Ispizua A., Zuazu J., Ojeda E., Bargay J., Moraleda J.M., Bailen A., Sierra J., García-Conde J., and Rozman C. (1998). Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Bone Marrow Transplant, 22, 1129-1135.
40. Matsuda Y., Hara J., Osugi Y., Fujisaki H., Takai K., Ohta H., Nakanishi K., Tokimasa S., Miyoshi H., Tanaka-Taya K., Yamanishi K., and Okada S. (1998). Allogeneic peripheral stem cell transplantation using positively selected CD34+ cells from HLA-mismatched donors. Bone Marrow Transplant, 21, 355-360.
41. Bomberger C., Singh-Jairam M., Rodey G., Guerriero A., Yeager A.M., Fleming W.H., Holland H.K., and Waller E.K. (1998). Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors. Blood, 91, 2588-2600.
42. Link H., Arseniev L., Ljungman P., Alessandrino E.P., Amadori S., Bandini G., Beguin Y., Brinch L., Brunet S., Chopra R., Cordonnier C., De Witte T., Fauser A., Ferrant A., García-Conde J., Juliusson G., Kubel M., Manna A.T., Martmez-Rubio A.M., Mundhenk P., Ordemann R., Ortega J.J., Potter M., Prentice H.G., Raimondi R., Remez K., Reusser P., Rovira M., Russell J., Selleslag D., Uderzo C., and Zaucha J.M. (1998). Cytomegalovirus infections after allogeneic peripheral blood progenitor cell transplantation: a survey of the infectious disease working party of the EBMT. Bone Marrow Transplant, 21 (Suppl. 1), 5139.
43. Urbano-Ispizua A., Rozman C., Martínez C., Marín P., Briones J., Rovira M., Féliz P., Viguria M.C., Merino A., Sierra J., Mazzara R., Carreras E., and Montserrat E. (1997). Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood. Blood, 89, 3967-3973.